Xponance, Inc. Moderna, Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 45,184 shares of MRNA stock, worth $1.67 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

45,184

Previous 44,072 2.52%

Holding current value

$1.67 Million

Previous $5.23 Million 42.31%

% of portfolio

0.03%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$63.64 - $125.14 $70,767 - $139,155	1,112 Added 2.52%	45,184 $3.02 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $39,168 - $64,478	-387 Reduced 0.87%	44,072 $5.23 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $175,008 - $236,652	2,050 Added 4.83%	44,459 $4.74 Million
Q4 2023 Jan 31, 2024	BUY	$69.51 - $104.43 $173,010 - $259,926	2,489 Added 6.23%	42,409 $4.22 Million
Q3 2023 Oct 23, 2023	BUY	$96.41 - $126.61 $87,733 - $115,215	910 Added 2.33%	39,920 $4.12 Million
Q2 2023 Jul 13, 2023	SELL	$118.5 - $160.53 $430,036 - $582,563	-3,629 Reduced 8.51%	39,010 $4.74 Million
Q1 2023 Apr 17, 2023	SELL	$135.66 - $197.02 $373,471 - $542,396	-2,753 Reduced 6.06%	42,639 $6.55 Million
Q4 2022 Jan 23, 2023	BUY	$118.38 - $210.04 $648,604 - $1.15 Million	5,479 Added 13.73%	45,392 $0
Q3 2022 Oct 24, 2022	BUY	$118.07 - $194.18 $1.1 Million - $1.81 Million	9,307 Added 30.41%	39,913 $4.72 Million
Q2 2022 Aug 02, 2022	SELL	$117.13 - $176.59 $3.23 Million - $4.87 Million	-27,604 Reduced 47.42%	30,606 $4.37 Million
Q1 2022 Apr 20, 2022	SELL	$126.46 - $235.05 $379,127 - $704,679	-2,998 Reduced 4.9%	58,210 $10 Million
Q4 2021 Jan 31, 2022	BUY	$225.82 - $368.51 $1.13 Million - $1.84 Million	4,984 Added 8.86%	61,208 $15.5 Million
Q3 2021 Nov 05, 2021	BUY	$221.9 - $484.47 $3.69 Million - $8.06 Million	16,646 Added 42.06%	56,224 $21.6 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $1.24 Million - $2.24 Million	9,543 Added 31.77%	39,578 $9.3 Million
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $48,148 - $82,017	441 Added 1.49%	30,035 $3.93 Million
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $10,189 - $26,328	-155 Reduced 0.52%	29,594 $3.09 Million
Q3 2020 Oct 26, 2020	BUY	$54.34 - $94.85 $97,648 - $170,445	1,797 Added 6.43%	29,749 $2.11 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $829,335 - $2.24 Million	27,952 New	27,952 $1.8 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account